SG Americas Securities’s DexCom DXCM Stock Holding History

SG Americas Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8K	Hold	13,700	–	–	﹤0.01%	3140
2025 Q4	$42K	Hold	13,700	–	–	﹤0.01%	3385
2025 Q3	$68K	Buy	+13,700	New	+$1.08M	﹤0.01%	3150
2025 Q2	–	Sell	-62,000	Closed	-$29K	–	3109
2025 Q1	$29K	Sell	62,000 -68,000	-52%	-$5.55M	﹤0.01%	3340
2024 Q4	$324K	Buy	130,000 +95,000	+271%	+$7.03M	﹤0.01%	1718
2024 Q3	$6K	Buy	+35,000	New	+$2.87M	﹤0.01%	3384
2024 Q2	–	Sell	-20,000	Closed	-$466K	–	2959
2024 Q1	$466K	Hold	20,000	–	–	﹤0.01%	1462
2023 Q4	$367K	Hold	20,000	–	–	﹤0.01%	1671
2023 Q3	$128K	Buy	+20,000	New	+$2.25M	﹤0.01%	2619
2022 Q4	–	Sell	-65,000	Closed	-$306K	–	3133
2022 Q3	$306K	Buy	+65,000	New	+$5.51M	﹤0.01%	1973

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SG Americas Securities's DXCM Position: Q1 2026 in Review

SG Americas Securities increased its DexCom (DXCM) stake by 282% in Q1 2026, buying an estimated $106M and bringing the position to 2,065,277 shares worth $130M. The position accounts for 0.14% of the portfolio, ranked #123.

SG Americas Securities first reported a position in DXCM in Q3 2013 and has held it in 42 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

SG Americas Securities held 2,065,277 shares of DexCom worth $130M as of Q1 2026.
SG Americas Securities bought 1,524,219 DexCom shares in Q1 2026, an estimated $106M.
DexCom made up 0.14% of SG Americas Securities's portfolio in Q1 2026, its #123 holding.
SG Americas Securities first reported a position in DexCom in Q3 2013 and has held it in 42 quarters since.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.